The Rise of China: From Science Cities to Global Ambition
July 15, 2026
Daphne Smyth of Veristat on the rise of Chinese biopharma, regulatory realities, and what comes next
8 min read
False
July 15, 2026
Daphne Smyth of Veristat on the rise of Chinese biopharma, regulatory realities, and what comes next
8 min read
July 15, 2026
In the first installment of a new series on the investment environment in cell and gene therapy, Circio CEO Erik Wiklund explains how he had to get creative to raise funds in a difficult biotech market
10 min read
July 14, 2026
Researchers retrofit a lab-scale monoclonal antibody purification platform with automation, OPC-UA connectivity, and model-based flow control
3 min read
July 14, 2026
VIVEbiotech CEO Jon Alberdi lifts the lid on an eight-year collaboration focused on GMP lentiviral vectors for off-the-shelf solid tumor therapies
3 min read
July 13, 2026
Selected companies will receive earlier FDA engagement to support new US drug manufacturing facilities across small molecules, biologics, sterile injectables, and advanced therapies
2 min read
July 13, 2026
A targeted radiopharmaceutical improves CAR T activity in neuroblastoma models, engineered Tregs suppress allergic asthma, and new gene therapy platforms target MMA and the brain
4 min read
July 13, 2026
How targeted in vivo CAR T delivery could pave the way for autoimmune disease treatments
6 min read
July 10, 2026
Experts discuss how biopharma partnerships are evolving, as companies look beyond transactional supplier relationships toward more integrated, strategic, and collaborative models
14 min read
July 9, 2026
Circio CEO Erik Wiklund reflects on the discovery of human circular RNA and its evolution into a fast-moving therapeutic modality
11 min read
July 8, 2026
Elsevier’s Mirit Eldor explores the gap between AI adoption and AI confidence, drawing on findings from the Researcher of the Future report
7 min read
False
False
False
Affiliations:
Specialties:
Areas of Expertise: